Senju reports synthesis and evaluation of compounds with multiple pharmacological actions Dec. 8, 1998
Photogen initiates development of ocular disease Rx; receives U.S. patents for technology Dec. 7, 1998
Olopatadine combination more effective than loratadine monotherapy in allergic conjunctivitis Nov. 27, 1998
CytoTherapeutics receives patent protection for ocular delivery of therapeutic substances Nov. 25, 1998
First marketing approval granted for Vitrase in Mexico; U.S. phase III trials now under way Nov. 24, 1998
RSS